HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,826,166 | +9.2% | 15,785 | -2.9% | 0.00% | 0.0% |
| Q2 2023 | $1,671,723 | -19.0% | 16,254 | -14.1% | 0.00% | 0.0% |
| Q1 2023 | $2,064,712 | -60.0% | 18,918 | -58.2% | 0.00% | -66.7% |
| Q4 2022 | $5,156,166 | +84.8% | 45,309 | +0.5% | 0.01% | +50.0% |
| Q3 2022 | $2,790,000 | -17.4% | 45,089 | +6.4% | 0.01% | -14.3% |
| Q2 2022 | $3,379,000 | -27.6% | 42,359 | -4.5% | 0.01% | -12.5% |
| Q1 2022 | $4,667,000 | -2.0% | 44,359 | +0.4% | 0.01% | 0.0% |
| Q4 2021 | $4,761,000 | -2.6% | 44,180 | -1.0% | 0.01% | -11.1% |
| Q3 2021 | $4,890,000 | +15.1% | 44,647 | -1.6% | 0.01% | +12.5% |
| Q2 2021 | $4,247,000 | +1.7% | 45,365 | -0.0% | 0.01% | 0.0% |
| Q1 2021 | $4,178,000 | +30.8% | 45,385 | +4.0% | 0.01% | +14.3% |
| Q4 2020 | $3,194,000 | -6.6% | 43,653 | -0.8% | 0.01% | -12.5% |
| Q3 2020 | $3,420,000 | +22.8% | 44,012 | -12.2% | 0.01% | +14.3% |
| Q2 2020 | $2,786,000 | +156.1% | 50,110 | +36.5% | 0.01% | +133.3% |
| Q1 2020 | $1,088,000 | -22.8% | 36,713 | -5.6% | 0.00% | -25.0% |
| Q4 2019 | $1,409,000 | +20.1% | 38,910 | -9.7% | 0.00% | +33.3% |
| Q3 2019 | $1,173,000 | -14.2% | 43,110 | -24.1% | 0.00% | -25.0% |
| Q2 2019 | $1,367,000 | – | 56,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |